Ovarian Hyperstimulation Syndrome (OHSS) Risk

What is Ovarian Hyperstimulation Syndrome (OHSS) Risk?

Ovarian Hyperstimulation Syndrome, or OHSS, is a medical complication that can happen during fertility treatments. It occurs when the ovaries respond too strongly to hormone medications used in IVF and other assisted reproduction procedures. The ovaries become swollen and painful, and fluid can leak into the belly and chest.

OHSS ranges from mild to severe. Mild cases cause bloating and discomfort. Severe cases can lead to dangerous fluid buildup, blood clots, and kidney problems. In rare situations, OHSS can be life-threatening. The good news is that doctors can predict who is at higher risk before starting treatment. This allows them to adjust medication doses and protocols to prevent OHSS from happening.

Understanding your personal risk level helps you and your fertility doctor make safer treatment decisions. Blood tests that measure hormone levels can identify women who need modified treatment protocols. This proactive approach reduces complications and improves outcomes for women pursuing fertility treatment.

Anti-Mullerian Hormone (AMH), Female

Measures egg supply in ovaries.
Checks fertility potential for women.
Estimates remaining reproductive years.

^$235

Symptoms

Mild to moderate abdominal bloating and pain
Nausea and vomiting
Diarrhea
Rapid weight gain, often 5 to 10 pounds in a few days
Decreased urination despite drinking fluids
Shortness of breath or difficulty breathing
Tight or enlarged abdomen
Dizziness or lightheadedness
Severe abdominal pain in advanced cases
Blood clots in severe cases

Some women develop only mild symptoms that resolve on their own. Others experience severe symptoms that require hospitalization. Symptoms typically appear within a week after egg retrieval or ovulation trigger injection. Knowing your risk ahead of time helps you watch for early warning signs.

Causes and risk factors

OHSS happens when fertility medications overstimulate the ovaries. These medications contain follicle-stimulating hormone, or FSH, which causes multiple eggs to develop at once. In some women, the ovaries respond too aggressively. This leads to the release of substances that make blood vessels leaky. Fluid then escapes into surrounding body cavities. The trigger shot of human chorionic gonadotropin, or hCG, which helps eggs mature before retrieval, often sets off the syndrome in at-risk women.

Certain factors increase your risk significantly. Women with polycystic ovary syndrome, or PCOS, face higher risk because their ovaries contain many small follicles. Young age under 35 also increases risk. Having high levels of Anti-Mullerian Hormone, or AMH, above 3.5 to 4.0 ng/mL predicts greater OHSS risk. Low body weight, previous OHSS episodes, and having many follicles develop during stimulation all raise the chances. Knowing these risk factors before treatment allows doctors to personalize protocols and use lower medication doses.

How it's diagnosed

Doctors diagnose OHSS based on symptoms, physical exam, and imaging tests. Ultrasound shows enlarged ovaries and fluid in the abdomen. Blood tests check kidney function, blood thickness, and electrolyte balance. These tests help determine how severe the condition is.

The key to preventing OHSS is identifying high-risk women before fertility treatment starts. AMH testing measures your ovarian reserve and predicts how your ovaries will respond to stimulation. Women with AMH levels above 3.5 to 4.0 ng/mL face increased OHSS risk. Rite Aid offers AMH testing at Quest Diagnostics locations nationwide. Testing before you start fertility treatment helps your doctor create a safer protocol tailored to your body. This proactive approach prevents complications before they start.

Treatment options

Stop or reduce fertility medication doses immediately
Rest and avoid strenuous physical activity
Drink plenty of fluids, especially electrolyte drinks
Monitor weight daily and track symptoms
Use pain relievers like acetaminophen, avoiding NSAIDs
Wear compression stockings to prevent blood clots
Avoid sexual intercourse until symptoms resolve
In severe cases, drain excess fluid from the abdomen
Hospitalization for IV fluids and close monitoring if needed
Blood thinners if clotting risk is high
Freeze all embryos and delay transfer until recovery
For high-risk patients, use lower medication doses from the start
Consider using GnRH agonist trigger instead of hCG trigger

Prevention is the best treatment. Women at high risk benefit from modified protocols that use lower doses of stimulation medications. Your fertility doctor may also use different trigger medications or cancel the cycle if too many follicles develop. Getting tested before treatment allows for safer, personalized care.

Frequently asked questions

OHSS occurs when fertility medications cause the ovaries to respond too strongly, producing too many eggs at once. This leads to the release of chemicals that make blood vessels leaky. Fluid then escapes into the belly and chest. The hCG trigger shot often sets off the syndrome in women already at risk.

Women with PCOS, those under age 35, and anyone with high AMH levels above 3.5 to 4.0 ng/mL face increased risk. Low body weight, previous OHSS episodes, and having many follicles during stimulation also raise risk. Testing AMH before treatment helps identify high-risk patients so doctors can adjust protocols.

AMH measures the number of eggs remaining in your ovaries. High AMH levels indicate many follicles that could all respond to fertility medications at once. This increases the chance of overstimulation. AMH above 3.5 to 4.0 ng/mL signals that you need lower medication doses and careful monitoring during IVF.

Early symptoms include abdominal bloating, mild pain, nausea, and rapid weight gain within days of the trigger shot or egg retrieval. You may notice your clothes feel tight or your belly looks swollen. Decreased urination despite drinking fluids is another important sign that requires immediate medical attention.

Yes, prevention is possible for most women. Testing AMH before treatment identifies high-risk patients who need modified protocols. Doctors can use lower medication doses, different trigger shots, or freeze embryos instead of doing fresh transfers. These strategies significantly reduce OHSS risk while maintaining good pregnancy rates.

Seek immediate care if you have severe abdominal pain, persistent nausea and vomiting, decreased urination, shortness of breath, or rapid weight gain over 10 pounds. Dizziness, chest pain, or leg swelling also require emergency evaluation. Severe OHSS can cause blood clots and kidney problems that need hospital treatment.

Mild cases typically resolve within a week or two as hormone levels drop. Moderate cases may take several weeks to improve. If pregnancy occurs, OHSS can worsen and last longer because pregnancy hormones prolong ovarian stimulation. Severe cases requiring hospitalization may need weeks of treatment and monitoring.

OHSS itself does not reduce pregnancy rates. In fact, it often occurs in women whose bodies responded well to medications and produced many eggs. However, doctors may freeze embryos and delay transfer until you recover. This approach is safer and often results in better pregnancy outcomes than fresh transfer during active OHSS.

Mild OHSS causes bloating, discomfort, and slightly enlarged ovaries that resolve with rest and fluids. Severe OHSS involves dangerous fluid accumulation in the belly and chest, blood clots, kidney problems, and sometimes breathing difficulties. Severe cases require hospitalization for IV fluids, monitoring, and sometimes procedures to drain excess fluid.

Yes, AMH testing before treatment helps predict your personal risk level. This allows your fertility doctor to create a safer protocol tailored to your body. High-risk women benefit from lower medication doses and modified trigger protocols. Knowing your risk ahead of time prevents complications and improves your treatment experience.